Home About Us Government Relations and Advocacy Media Contact Us Site Map Privacy Français  
Multiple Sclerosis Society of CanadaSociété canadienne de la sclérose en plaquesfinding a cure - enhancing quality of life
Multiple Sclerosis Support & Services Research Treatments Donate Now Get Involved Special Events

 

How has MS affected you?


Living with Multiple Sclerosis
    share +

MS Updates

Welcome to MS Updates. On these pages you will find abstracts from a variety of credible sources related to MS information. MS Updates will include Canadian specific research findings or milestones, noteworthy international research findings, responses to external media releases as well as any other information that may influence the way in which individuals manage their MS.

RSS Feed   RSS feed
Subscribe to MS Updates by email by entering your email address below:

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. A Canadian flag beside a summary indicates that one or more of the contributing researchers or authors is Canadian.
MS Society of Canada Logo The MS Society logo beside a summary indicates that the MS Society of Canada has contributed funding to the work described.


2014



2013

November 28, 2013
Patterns of MS prevalence and care around the world

November 20, 2013
Health Canada approves third oral therapy in Canada for relapsing-remitting MS

November 19, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoMS Society funded study identifies antipsychotic drug as potential therapy for progressive MS

October 8, 2013
New data on CCSVI from Canadian study using ‘gold standard’ technique

September 4, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoMS Society-funded research aims at helping repair nerves damaged by MS

August 21, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoResults from MS Society of Canada funded study exploring CCSVI and MS in children

August 15, 2013
Copaxone only three times a week is effective for MS

August 1, 2013
Case of PML reported in European patient treated with Gilenya

July 30, 2013
MS Society of Canada LogoNew results from MS Society of Canada funded study exploring CCSVI and MS

July 9, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoMS Society supported study yields new information on "remyelination"

Reprogramming the immune system in people with MS

July 2, 2013
Latest in MS research presented at the 65th American Academy of Neurology Meeting

June 10, 2013
International Pediatric MS Study Group's Recommendations on Clinical Trials Published

April 9, 2013
Health Canada Approves TECFIDERA™ As A First-Line Oral Treatment For Multiple Sclerosis

April 8, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoCanadian study reveals subgroup of T cells which target oligodendrocytes in MS

April 5, 2013
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.MS Society of Canada LogoMultiple Sclerosis Scientific Research Foundation funded study advances understanding of risky but effective stem cell treatment for MS

March 13, 2013
New Studies on the Role of Salt in Autoimmunity

March 4, 2013
Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis

February 27, 2013
MS Society of Canada LogoCCSVI Case-Control Neurosonography Results Announced

2012

December 14, 2012
Early Relapses, Onset of Progression, and Late Outcome in MS

Changes in hospitalization rates and length of stay in people with MS

November 27, 2012
High levels of vitamin D among pregnant women are associated with reduced risk of developing MS later

November 26, 2012
Results of More Than 1,250 Studies Shared at Global MS Research Meeting

November 16, 2012
‘Month of birth’ effect in MS

November 15, 2012
Vaccinations and MS

November 5, 2012
Findings from two Phase III alemtuzumab studies for relapsing-remitting MS

November 2, 2012
Resistance training study showed an improvement in mobility and quality of life

October 22, 2012
Ginkgo biloba failed to improve cognitive function in people with MS

September 19, 2012
Promising results published on phase III trials of oral BG-12 for relapsing-remitting MS

September 17, 2012
FDA approves second oral medication for treatment of relapsing forms of MS

September 4, 2012
Researchers Continue With Their Progress in the Seven Funded CCSVI Studies in MS

August 24, 2012
Gilenya * Product Monograph Update

August 22, 2012
Low dose Ampyra does not improve walking speed in MS: results from a post-marketing study in the US

August 7, 2012
Preliminary results of a new class of oral drug that targets inflammation in neurodegenerative conditions reported

July 25, 2012
UBC Study observes natural improvement in MS-related disability

July 24, 2012
Health Canada and Novartis Pharmaceuticals Canada Inc. Revise Gilenya Label

FDA Warning About Risk of Seizures with MS Drug fampridine

Study Identifies Possible Target of Immune Attacks in Some People with MS

July 23, 2012
Phase II trial shows promising results for Masitinib for progressive multiple sclerosis

July 17, 2012
UBC study investigates the association between interferon beta therapy and disability progression in relapsing-remitting MS

July 3, 2012
Study assesses safety and efficacy of BOTOX® for management of tremor

June 25, 2012
Cancer risk in MS: Findings from a UBC study

May 24, 2012
Health Canada Approves Updates to TYSABRI® (natalizumab) Product Monograph to Include Anti-JC Virus Antibody Status

Small study reports benefit of cannabis on MS spasticity

Latest results about emerging MS therapies, risk factors, disease mechanisms, rehabilitation, CCSVI, and much more presented at AAN Meeting

May 18, 2012
US Food and Drug Administration revises recommendations for cardiovascular monitoring and use of Gilenya (fingolimod)

May 10, 2012
FDA issues safety communication about CCSVI and MS

April 13, 2012
A case of progressive multifocal leukoencephalopathy (PML) has been reported in an individual being treated with fingolimod (Gilenya)

April 12, 2012
FAMPYRA now available for prescription in Canada

March 13, 2012
Women’s risk for developing clinically isolated syndrome (CIS) was shown to decrease with increased number of pregnancies

February 29, 2012
Biogen Idec applies to FDA for approval of oral BG-12 to treat MS

February 28, 2012
Gilenya (fingolimod) under Health Canada review

February 27, 2012
Health Canada approves PrFAMPYRA™ (fampridine) for therapy to improve walking

February 17, 2012
Health Canada approves Botox® to treat neurogenic bladder

February 6, 2012
Study shows hydrotherapy may improve MS related pain

January 27, 2012
Research Teams Report on 18 Months of Progress from MS Societies' Initial Studies on CCSVI and MS

January 23, 2012
Fingolimod (Gilenya®) Under Review

January 1, 2012
Study Offers Insight on How Epstein-Barr Virus May Play a Role in MS

2011

December 19, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoNew MRI technique discovered by University of Alberta researchers will help track disease progression

December 15, 2011
Researchers identified that a gene that causes vitamin D deficiency may also cause MS

December 14, 2011
Possible Safety Issue Being Investigated with Novartis Pill Gilenya

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoDecember 2, 2011
Researchers reveal a dual-protective role of the Hedgehog pathway

November 29, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoMS Society of Canada announces $3.8 million to study progressive forms of multiple sclerosis

November 25, 2011
Common Drug Review Recommends Listing Fingolimod (Gilenya™) Under Public Drug Programs

MS Society of Canada Collaborates with CIHR in Call for CCSVI Clinical Trial Research Proposals

November 16, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoNeuroinflammation and Endoplasmic Reticulum Stress are Co-regulated by Crocin to Prevent Demyelination and Neurodegeneration

November 14, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoMRI parameters identified for prediction of MS diagnosis in children with acute CNS demyelination

November 9, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoNeurons Susceptible to Neuronal Damage through a Novel Mechanism Mediated by Granzyme B

November 7, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Research Team Discovers New Type of Spinal Cord Stem Cell

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoB Cell-Derived IL-15 Enhances CD8 T Cell Cytotoxicity and is Increased in MS

November 4, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada LogoImpaired neurosteroid synthesis in multiple sclerosis

October 6, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Teriflunomide: Positive Results Reported Following a Phase III Study

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.September 30, 2011
Government of Canada Funds National Neurological Study

August 5, 2011
Breakthrough in the Search for New Treatments for MS

Poor Bone Health May Start Early in MS

July 20, 2011
New Study on Cost Effectiveness of MS Therapies

July 15, 2011
Merck Serono will not proceed with FDA approval of oral cladribine

July 14, 2011
Research Teams Report First Year’s Progress From MS Societies’ Initial Studies on CCSVI and MS

July 1, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.The psychosocial and cognitive impact of longstanding benign MS

June 27, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Pregnancy outcomes in women with multiple sclerosis

June 10, 2011
Increased Risk of Multiple Sclerosis Following Occurrence of Shingles

June 3, 2011
Avonex® PenTM Autoinjector Approved by Health Canada

May 11, 2011
MS Research Progress Takes Center Stage at American Academy of Neurology’s Annual Meeting

March 10, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.First Oral Disease-Modifying Therapy Approved in Canada (Gilenya®)

January 31, 2011
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian. MS Society of Canada Logo Research Teams Report Progress from First Six Months of 2-Year Projects Focusing on CCSVI and MS

2010

November 18, 2010
Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

November 4, 2010
Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon beta

November 2, 2010
MS Researchers Share Progress at Annual ECTRIMS Conference

October 27, 2010
Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study

A randomised controlled trial: outcomes of bladder rehabilitation in persons with multiple sclerosis

October 21, 2010
Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect

MS quality of life, depression, and fatigue improve after mindfulness training

October 14, 2010
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue

October 8, 2010
Pathophysiology of multiple sclerosis and the place of teriflunomide

September 16, 2010
MS Society of Canada LogoCalnexin Deficiency Leads to Dysmyelination

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.The natural history of secondary progressive multiple sclerosis

September 9, 2010
A method for evaluating treatment switching criteria in multiple sclerosis

Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study

August 27, 2010
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Emerging effects of comorbidities on multiple sclerosis

Fatigue, sleepiness, and physical activity in patients with multiple sclerosis

August 23, 2010
MS Society of Canada LogoA ChIP-seq-defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution

August 19, 2010
Modifiable factors influencing relapses and disability in multiple sclerosis

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies

Recent Papers Highlight Difficulty of Studying Long-Term Impact on Progression of MS Disease-Modifying Therapies

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

August 10, 2010
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis

Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

August 5, 2010
A Home-Based Walking Program Using Rhythmic Auditory Stimulation Improves Gait Performance in Patients With Multiple Sclerosis: A Pilot Study

The Effect of Microvascular Decompression in Patients With Multiple Sclerosis and Trigeminal Neuralgia

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.The natural history of secondary progressive multiple sclerosis

July 29, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Executive Functioning in Children and Adolescents with Multiple Sclerosis

Nocebo effects in multiple sclerosis trials: a meta-analysis

Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course

July 22, 2010
Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients

July 20, 2010
Two Medical Meetings (ACTRIMS and CMSC) Focus on Research Progress and Issues in MS Clinical Care

July 12, 2010
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.

July 6, 2010
A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS

A Canadian flag beside a summary indicates that one or more of the contributing researchers is Canadian.Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

July 1, 2010
Work from 3 Canadian MS Clinics published : Vancouver, London and TorontoNew perspectives in the natural history of multiple sclerosis

Work from 3 Canadian MS Clinics published : Vancouver, London and TorontoThe natural history of multiple sclerosis, a geographically based study: relapses and long-term disability

Work from 3 Canadian MS Clinics published : Vancouver, London and TorontoIncreasing use of disease modifying drugs for MS in Canada

June 23, 2010
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial

Cross-sectional study assessing long-term safety of interferon-{beta}-1b for relapsing-remitting MS

June 21, 2010
Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance

June 14, 2010
MRI only conversion to multiple sclerosis following a clinically isolated syndrome

June 7, 2010
What is the risk of permanent disability from a multiple sclerosis relapse?

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis

June 3, 2010
Vitamin D and multiple sclerosis

Progress on Experimental Therapies for MS, CCSVI Forum, and Much More, Reported at the American Academy of Neurology Meeting

June 1, 2010
Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis

Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial

May 31, 2010
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS

May 25, 2010
Researchers pave way for the first coordinated international approach to MS stem cell research

Psychosocial issue in children and adolescents with multiple sclerosis

May 19, 2010
Crossover trial of gabapentin and memantine as treatment for acquired nystagmus

May 10, 2010
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices

Study Suggests that Smoking and Exposure to Epstein-Barr Virus May Interact as Risk Factors for Developing MS

April 26, 2010
Disease onset in familial and sporadic primary progressive multiple sclerosis

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

April 22, 2010
Relationship of cortical atrophy to fatigue in patients with multiple sclerosis

Clinical trial of a formal group fatigue program in multiple sclerosis

April 7, 2010
Pediatric focus continues to shed new light on MS

March 23, 2010
Five Studies explore relationship between Epstein-Barr Virus and MS

March 17, 2010
Early cognitive impairment in multiple sclerosis predicts disability outcome several years later

Ibudilast in relapsing-remitting multiple sclerosis

March 16, 2010
Antiviral immune response in patients with multiple sclerosis and healthy siblings

March 4, 2010
Results of Phase II "CHOICE" Study Published, Showing that Daclizumab Reduced Disease Activity in Relapsing MS, and Revealing Novel Immune Mechanism

March 3, 2010
Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis

MRI of the corpus callosum in multiple sclerosis: association with disability

Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene

March 1, 2010
Atorvastatin Combined with Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

February 16, 2010
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis

February 2, 2010
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba

January 29, 2010
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis

January 28, 2010
Results Published from Phase 3 Study of Oral Cladribine in Relapsing-Remitting MS

January 27, 2010
Positive Results Published on Clinical Trials of Oral FTY720 (Fingolimod) for Relapsing MS - Novartis Applies to FDA and European Regulatory Agency for Approval

January 26, 2010
Regional brain atrophy in primary fatigued patients with multiple sclerosis

January 21, 2010
No Effect of Parental Age on Risk of Multiple Sclerosis: A Population-Based Study

January 12, 2010
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

January 11, 2010
A randomized trial of memantine as treatment for spasticity in multiple sclerosis

January 8, 2010
HLA-DRB1 and month of birth in multiple sclerosis

January 4, 2010
Callosal lesion predicts future attacks after clinically isolated syndrome

A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.

Back to top

2009

December 10, 2009
Positive Results Announced in Phase II Study of IV Ocrelizumab in Relapsing-Remitting MS

November 24, 2009
Body size and risk of MS in two cohorts of US women

November 21, 2009
Chronic cerebrospinal venous insufficiency (CCSVI) and MS - Overview and FAQ

November 18, 2009
Impact of Multiple Sclerosis Relapses on Progression Diminishes with time

November 9, 2009
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

October 27, 2009
Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis

Consideration of the risk of secondary leukemia after mitoxantrone in multiple sclerosis populations is required

October 20, 2009
Two reports for Management of Trigeminal Neuralgia in Multiple Sclerosis

PreCISe Study Results – Showing Benefit of Copaxone® in People at High Risk for MS

October 15, 2009
Therapeutic Strategies for MS and More Highlighted at ECTRIMS Conference

October 13, 2009
Preliminary work suggests that minocycline as add-on therapy may offer improved efficacy of glatiramer acetate in relapsing-remitting multiple sclerosis. Authors suggest further research needed.

September 22, 2009
250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Asymptomatic reactivation of JC virus in patients treated with natalizumab

September 10, 2009
Correlation between disability and transcranial magnetic stimulation abnormalities in patients with multiple sclerosis

September 9, 2009
Effect of immigration on multiple sclerosis female to male ratio in Canada: the Canadian Collaborative Study

September 3, 2009
Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis

Gestational diabetes and multiple sclerosis

September 2, 2009
Care Given to People with MS by Family Members Presents Unique Challenges - Study funded by National MS Society points to need for respite and mental health support for family care givers

August 31, 2009
Sponsor Reports Positive Results of Clinical Trial of Zenvia™ for Pseudobulbar Affect (Uncontrollable Laughing and/or Crying)

August 18, 2009
Pilot study of a cognitive intervention program for persons with multiple sclerosis.

July 30, 2009
The impact of physical activity on fatigue, depression and quality of life in persons with multiple sclerosis

July 29, 2009
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial In Secondary Progressive Multiple Sclerosis

July 28, 2009
Study Adds Evidence that Smoking Worsens MS, and Quitting May Help

July 22, 2009
"Benign” Course of MS Evaluated with MRI and Other Imaging Methods by European Collaborators

July 6, 2009
Parent-of-origin effect in multiple sclerosis. Observations from interracial matings

Age of onset in concordant twins and other relative pairs with multiple sclerosis

Two Studies Report Finding New Genes and Gene Regions that Make People Susceptible to MS

June 29, 2009
Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction

Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a

June 24, 2009
Two Medical Meetings (ACTRIMS and CMSC) Focus on MS Risk Factors and Quality of Life Issues

June 23, 2009
Remyelination capacity of the MS brain decreases with disease chronicity

June 17, 2009
Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria

June 15, 2009
Randomized Clinical Trial of Balance-Based Torso Weighting for Improving Upright Mobility in People with Multiple Sclerosis

June 9, 2009
Report of American Academy of Neurology Meeting Seattle April 2009

June 8, 2009
Parity and secondary progression in multiple sclerosis

May 26, 2009
Update on oral therapies for MS reported at the American Academy of Neurology Meeting

May 19, 2009
Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease

May 14, 2009
The relationship between handedness and risk of multiple sclerosis

May 11, 2009
Multiple Sclerosis and Academic Work: Socio-Spatial Strategies Adopted to Maintain Employment

May 4, 2009
The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosisrelated neurogenic bladder dysfunction

April 30, 2009
Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T

The search for responsive clinical endpoints in primary progressive multiple sclerosis

April 20, 2009
Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors

April 14, 2009
Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study

March 25, 2009
Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study

March 18, 2009
Studies Reported: Function, Combination Drug Therapy, Cognition, and Causation

March 17, 2009
Genetics Studies Yield New Clues to Why People Get MS

March 16, 2009
New Studies Bolster Possible Link Between Epstein-Barr Virus and MS

March 6, 2009
Predicting accidental falls in people with multiple sclerosis -- a longitudinal study

March 3, 2009
Young Smokers Increase Risk for Multiple Sclerosis

March 3, 2009
Breastfeeding may have an impact on reducing Multiple Sclerosis Relapses

February 23, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remittng MS

February 11, 2009
Incidence of acquired demyelination of the central nervous system in Canadian children

February 9, 2009
Researchers Report Good Results from Small Study of Stem Cell Therapy to “Reboot” Immune System in MS

February 5, 2009
Genetic study supports vitamin D deficiency as an environmental factor in MS susceptibility

January 28, 2009
Oral Cladribine Reduces MS Relapses in Phase 3 Clinical Trial

January 15, 2009
Restless Leg Syndrome in multiple sclerosis:A case-control study

January 8, 2009
Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.

January 5, 2009
Oral FTY720 (Fingolimod) Reduced Relapse Rate More Effectively Than Avonex in Initial Results of One-Year Study in Relapsing-Remitting MS

January 5, 2009
Dr. Brenda Banwell, a well known Canadian pediatric researcher, is an author on 2 papers about the use of MRI in children with MS, published in Neurology.
2008 Nov 26 (Epub ahead of print).

Back to top

2008

November 17, 2008
Researchers find a key player in the maintenance of myelin

November 13, 2008
Researchers demonstrate a potential association between monthly ambient sunlight, infections and relapse rates in Multiple Sclerosis
(Neuroepidemiology 2008, 31: 271-279)

November 4, 2008
Results Published: Oral Drug BG00012 Reduced MRI Inflammation in Relapsing-Remitting MS During Phase 2 Trial

November 3, 2008
Alemtuzumab Results Published: Reduced MS Relapses and Accumulation

October 27, 2008
Teams Funded by the National MS Society Report on Key Enzymes Related to MS Progression and Nervous System Repair

October 16, 2008
Investigators Find No Overall Link Between Hepatitis B Vaccine and MS

October 2, 2008
World congress on MS takes place in Montreal

September 10, 2008
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women

September 3, 2008
New Recommendations from the FDA Concerning the Monitoring of Cardiac Function in People Taking Mitoxantrone

August 21, 2008
Canadian Collaborative Project on Genetic Susceptibility to MS provides data to study exploring risk of developing MS for preterm babies

August 18, 2008
Researchers suggest that latitude and sex ratio trends in the incidence of multiple sclerosis may be shifting

August 13, 2008
Biogen Idec and Elan Pharmaceuticals informed drug regulatory authorities about two new confirmed cases of PML(progressive multifocal leukoencephalopathy) in individuals who were taking Tysabri® (natalizumab) as a monotherapy (not in combination with other therapies).

August 13, 2008
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

August 13, 2008
Sleep problems in people with MS are prevalent

July 7, 2008
Effectiveness of Rehabilitation Intervention in Persons with Multiple Sclerosis: A randomized controlled trial

July 3, 2008
Laquinimod Results Published: Oral Drug Reduces Disease Activity in Phase 2 Study

June 27, 2008
Molecule Strikes Balance in Immune System and May Be Key to Autoimmune Attack in MS

June 13, 2008
Serious Infections Experienced by Two People Participating in Clinical Trials of FTY720 for MS

June 11, 2008
Fampridine-SR Improves Walking Speed in All Types of MS in Second Phase 3 Study

June 10, 2008
New Study Suggests Immune Genes Help Determine Sites of MS Damage and Symptoms

May 23, 2008
Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology Meeting

May 15, 2008
Stem Cell Treatments in China

April 29, 2008
Disappointing Results from Trial of Rituximab in Primary Progressive MS

April 22, 2008
Investigators Explore MS Risk Conferred by Combination of Gene and Virus

April 21, 2008
Norwegian Researchers Confirm Higher Rates of Symptoms of Depression and Anxiety in People with MS

April 3, 2008
Combined treatment with atorvastatin and minocycline suppresses severity of EAE

April 2, 2008
Acne medication may delay progress of multiple sclerosis

March 27, 2008
Compound Protects Nerves from Injury in National MS Society-funded Study of Mice with Progressive MS

February 28, 2008
"Street" Marijuana Harmful to Cognitive Function in MS Patients

February 19, 2008
Phase ll trial suggests Rituximab may reduce MS Disease Activity

January 16, 2008
MS Therapy may help delay conversion from CIS to clinically definite MS

January 11, 2008
Two year pilot study suggests that combination therapy with interferon Beta-1b and azathioprine may help slow the course of SPMS

January 9, 2008
Large-scale analysis from Nova Scotia suggests that disease-modifying drugs for MS are effective in reducing disability progression in people whose MS started with relapses

Back to top

2007

November 6, 2007
Researchers Report Findings on Antibody That Stimulates Myelin Repair

October 31, 2007
Research Progress Reported at International ECTRIMS Meeting

October 31, 2007
Eye Scan May Help Diagnose, Treat MS

October 25, 2007
Acne medication may delay progress of multiple sclerosis

September 19, 2007
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children

August 17, 2007
Experimental MS vaccine shows beneficial changes in immune system

August 14, 2007
Interferon injection may delay disability accumulation

August 8, 2007
Study Finds Early Sun Exposure Associated with Reduced Risk of MS

July 31, 2007
International Collaborators Identify New Genetic Risk Factors for MS

July 25, 2007
A timing-of-birth effect on risk for multiple sclerosis

July 23, 2007
Immune system variations may underlie differences in MS between African Americans and Caucasians

July 18, 2007
ACTRIMS and CMSC meetings focus on emerging MS therapies and quality of life issues

June 2007
MS Disease-Modifying Therapies in Canada only

May 24, 2007
Easier access to multiple sclerosis treatments will reduce overall healthcare costs: MS Society

May 8, 2007
The Canadian endMS Research Conference - Banff, Alberta - December 10 to 13, 2007

May 2007
Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology Meeting - April 28 to May 4, 2007

April 13, 2007
Researchers Stop MS-like disease in Mice by Targeting a Blood Protein

April 13, 2007
Frequently Asked Questions on Tysabri

February 22, 2007
Clinical trial of oral therapy in relapsing remitting MS

February 22, 2007
Pregnancy hormone key to repairing nerve cell damage

February 12, 2007
Benign MS

January 29, 2007
Clinical trial results for oral therapy fingolimod show reduction of disease activity: Larger study now recruiting participants

January 24, 2007
Clinical trial of MBP8298 expands to United States

January 4, 2007
Later onset of MS does not necessarily lead to worse outcome: University of British Columbia study

Back to top

Archives »

Back to top

line
Charitable registration
10774 6174 RR0001
Multiple Sclerosis Society of Canada
Toll free to reach the nearest regional office: 1 800 268-7582

To locate the MS Society office near you, please select your region:

E-mail: info@mssociety.ca
(Please provide your town and province in your e-mail)

Multiple Sclerosis   Living with MS   Research   Treatments   Donate Now   Get Involved    Special Events

Home    About Us    Advocacy    Media    Contact Us    Site Map    Privacy    Français